Preeclampsia or Placenta Previa; Extravillous Trophoblast Cells Are Determinative

authors:

avatar Nadia Sheibak ORCID 1 , *

Department of Histology, School of Medicine, Zahedan University of Medical Sciences, Zahedan, Iran

how to cite: Sheibak N. Preeclampsia or Placenta Previa; Extravillous Trophoblast Cells Are Determinative. Gene Cell Tissue. 2019;6(1):e89702. https://doi.org/10.5812/gct.89702.

References

  • 1.

    Adam I, Haggaz AD, Mirghani OA, Elhassan EM. Placenta previa and pre-eclampsia: Analyses of 1645 cases at medani maternity hospital, Sudan. Front Physiol. 2013;4:32. [PubMed ID: 23450096]. [PubMed Central ID: PMC3584291]. https://doi.org/10.3389/fphys.2013.00032.

  • 2.

    Faiz AS, Ananth CV. Etiology and risk factors for placenta previa: An overview and meta-analysis of observational studies. J Matern Fetal Neonatal Med. 2003;13(3):175-90. [PubMed ID: 12820840]. https://doi.org/10.1080/jmf.13.3.175.190.

  • 3.

    Ying H, Lu Y, Dong YN, Wang DF. Effect of placenta previa on preeclampsia. PLoS One. 2016;11(1). e0146126. [PubMed ID: 26731265]. [PubMed Central ID: PMC4701488]. https://doi.org/10.1371/journal.pone.0146126.

  • 4.

    Pinheiro MB, Gomes KB, Ronda CR, Guimaraes GG, Freitas LG, Teixeira-Carvalho A, et al. Severe preeclampsia: Association of genes polymorphisms and maternal cytokines production in Brazilian population. Cytokine. 2015;71(2):232-7. [PubMed ID: 25461403]. https://doi.org/10.1016/j.cyto.2014.10.021.

  • 5.

    Heidari Z, Sakhavar N, Mahmoudzadeh-Sagheb H, Ezazi-Bojnourdi T. Stereological analysis of human placenta in cases of placenta previa in comparison with normally implanted controls. J Reprod Infertil. 2015;16(2):90-5. [PubMed ID: 25927025]. [PubMed Central ID: PMC4386091].

  • 6.

    Lash GE, Otun HA, Innes BA, Kirkley M, De Oliveira L, Searle RF, et al. Interferon-gamma inhibits extravillous trophoblast cell invasion by a mechanism that involves both changes in apoptosis and protease levels. FASEB J. 2006;20(14):2512-8. [PubMed ID: 17142800]. https://doi.org/10.1096/fj.06-6616com.

  • 7.

    Banerjee S, Smallwood A, Moorhead J, Chambers AE, Papageorghiou A, Campbell S, et al. Placental expression of interferon-gamma (IFN-gamma) and its receptor IFN-gamma R2 fail to switch from early hypoxic to late normotensive development in preeclampsia. J Clin Endocrinol Metab. 2005;90(2):944-52. [PubMed ID: 15585559]. https://doi.org/10.1210/jc.2004-1113.

  • 8.

    Sheibak N. The role of hypoxia in normal pregnancy and pregnancy complications. Gene Cell Tissue. 2018;5(2). https://doi.org/10.5812/gct.80202.

  • 9.

    Lockwood CJ, Basar M, Kayisli UA, Guzeloglu-Kayisli O, Murk W, Wang J, et al. Interferon-gamma protects first-trimester decidual cells against aberrant matrix metalloproteinases 1, 3, and 9 expression in preeclampsia. Am J Pathol. 2014;184(9):2549-59. [PubMed ID: 25065683]. [PubMed Central ID: PMC4188280]. https://doi.org/10.1016/j.ajpath.2014.05.025.

  • 10.

    Murphy MS, Tayade C, Smith GN. Evidence of inflammation and predisposition toward metabolic syndrome after pre-eclampsia. Pregnancy Hypertens. 2015;5(4):354-8. [PubMed ID: 26597753]. https://doi.org/10.1016/j.preghy.2015.09.007.